Loading…
Colinz Laboratories (BSE 531210)₹70.00+1.46%Pharmaceuticals
Colinz Laboratories is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 6.4 against a peer median of 25.3, and ROCE of 7.2% against a peer median of 6.6%, and latest-quarter sales growth of −21.2% against a peer median of 0.1%. By market cap it is #7 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Walpar Nutritions | 24 | 9.5 | 14.9 | 13.9 | 0.89 | 0.0 | 79 | 3 | 7.8 | 6.4 | vs BSE 531210 |
| Ishita Drugs & Industries | 22 | 28.3 | 8.6 | 7.0 | 0.01 | 0.0 | 15 | 1 | −32.8 | −36.7 | vs BSE 531210 |
| Venmax Drugs & Pharmaceuticals | 21 | 54.3 | 3.0 | 2.7 | 0.02 | 0.0 | 8 | 0 | 1,128.1 | −87.0 | vs BSE 531210 |
| Span Divergent | 20 | — | −30.0 | −41.5 | 0.48 | 0.0 | 17 | −3 | −4.6 | — | vs BSE 531210 |
| Mono Pharmacare | 18 | 52.6 | 5.0 | 1.1 | 1.78 | 0.0 | 166 | 0 | 22.1 | −100.0 | vs BSE 531210 |
| Centuple Global | 18 | 11.6 | 15.0 | 12.7 | 0.29 | 0.0 | 575 | 2 | 1,07,642.3 | −1,040.0 | vs BSE 531210 |
| Colinz Laboratories | 18 | 6.4 | 7.2 | 5.3 | 0.04 | 0.0 | 6 | 1 | −21.2 | 1,753.8 | — |
| Zenith Health Care | 17 | — | 0.3 | 0.1 | 0.00 | 0.0 | 10 | 0 | −23.7 | −430.0 | vs BSE 531210 |
| Starsource Multitrade | 17 | — | −163.9 | −164.0 | 0.00 | 0.0 | 1 | −12 | — | — | vs BSE 531210 |
| Desh Rakshak Aushdhalaya | 14 | 22.3 | 6.6 | 4.9 | 0.21 | 0.0 | 7 | 1 | −21.5 | −17.1 | vs BSE 531210 |
| Beryl Drugs | 13 | 31.1 | 7.2 | 4.3 | 0.25 | 0.0 | 19 | 0 | 4.8 | 292.9 | vs BSE 531210 |
| Peer median | 18 | 25.3 | 6.6 | 4.3 | 0.21 | 0.0 | 15 | 0 | 0.1 | −36.7 |
Listed companies closest to Colinz Laboratories in Pharmaceuticals include Walpar Nutritions, Ishita Drugs & Industries, Venmax Drugs & Pharmaceuticals, Span Divergent, Mono Pharmacare, Centuple Global, Zenith Health Care, Starsource Multitrade.
Walpar Nutritions, with a market cap of ₹23.50 Cr.
Colinz Laboratories trades at a P/E of 6.4; the median of its peer set is 25.3. A P/E above or below the median is a description, not a judgement on value.
Colinz Laboratories' return on capital employed is 7.2%, above the peer median of 6.6%.